Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher	pref label
tabling member	label

Search

1608437

human indexable
published
registered interest
answer date	13/04/2023
date	28/03/2023
date tabled	28/03/2023
ddp created	28/03/2023 21:31:53
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	28/03/2023 21:46:57 24/04/2023 15:17:19
hansard heading	Coronavirus: Vaccination
house id	2
identifier	HL6943
legislature	25277 pref label House of Lords
parliament number	58
question first answered	24/04/2023 14:45:48
question text	To ask His Majesty's Government, further to the statement by the Joint Committee on Vaccination and Immunisation COVID-19 vaccination programme for 2023: JCVI interim advice, 8 November 2022, what estimate they have made of the number of vaccinations required to prevent a COVID-19 hospital admission for individuals in clinical risk groups, as outlined in the Green Book; and whether they will provide a link to Appendix A of this statement.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL6943
type	WrittenParliamentaryQuestion
uin	HL6943
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn

1604684

human indexable
published
registered interest
answer date	29/03/2023
date	15/03/2023
date tabled	15/03/2023
ddp created	15/03/2023 21:52:10
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	15/03/2023 21:56:31 12/04/2023 12:04:15
hansard heading	Evusheld
house id	2
identifier	HL6531
legislature	25277 pref label House of Lords
parliament number	58
question first answered	12/04/2023 11:32:54
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 6 March (HL5937), why the National Institute for Clinical Excellence (NICE) request for referral of 8 June is described as for “referral of Evusheld for treatment of COVID-19” but, as confirmed in a NICE freedom of information response, the request was for “referral of tixagevimab-cilgavimab for preventing COVID-19 [ID6136] on 8 June 2022”, causing delay to the possibility of a decision at a time when the preventative prophylaxis Evusheld was highly efficacious.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL6531
type	WrittenParliamentaryQuestion
uin	HL6531
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn

1608434

human indexable
published
registered interest
answer date	13/04/2023
date	28/03/2023
date tabled	28/03/2023
ddp created	28/03/2023 21:31:47
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	28/03/2023 21:46:49 12/04/2023 14:03:15
hansard heading	Coronavirus: Vaccination
house id	2
identifier	HL6940
legislature	25277 pref label House of Lords
parliament number	58
question first answered	12/04/2023 13:31:48
question text	To ask His Majesty's Government what (1) evidential basis, and (2) rationale, the Joint Committee on Vaccination and Immunisation used to determine that family members of, and carers for, people in the clinical risk groups identified in the Green Book are not recommended to receive COVID-19 booster vaccinations.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL6940
type	WrittenParliamentaryQuestion
uin	HL6940
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn

1608435

human indexable
published
registered interest
answer date	13/04/2023
date	28/03/2023
date tabled	28/03/2023
ddp created	28/03/2023 21:31:48
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	28/03/2023 21:46:52 12/04/2023 14:10:18
hansard heading	Coronavirus: Disease Control
house id	2
identifier	HL6941
legislature	25277 pref label House of Lords
parliament number	58
question first answered	12/04/2023 13:39:05
question text	To ask His Majesty's Government, following the decision by the Joint Committee on Vaccination and Immunisation that family members of, and carers for, people in the clinical risk groups are not recommended to receive COVID-19 booster vaccinations, what steps they are taking to protect people in clinical risk groups from contracting COVID-19.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL6941
type	WrittenParliamentaryQuestion
uin	HL6941
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn

1608436

human indexable
published
registered interest
answer date	13/04/2023
date	28/03/2023
date tabled	28/03/2023
ddp created	28/03/2023 21:31:50
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	28/03/2023 21:46:54 12/04/2023 14:13:14
hansard heading	Joint Committee on Vaccination and Immunisation: Disclosure of Information
house id	2
identifier	HL6942
legislature	25277 pref label House of Lords
parliament number	58
question first answered	12/04/2023 13:41:41
question text	To ask His Majesty's Government whether the minutes of the Joint Committee on Vaccination and Immunisation meeting that set out the clinical risk groups for the COVID-19 vaccination programme in Spring 2023 will be made available to the public.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL6942
type	WrittenParliamentaryQuestion
uin	HL6942
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn

1608438

human indexable
published
registered interest
answer date	13/04/2023
date	28/03/2023
date tabled	28/03/2023
ddp created	28/03/2023 21:31:55
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	28/03/2023 21:46:59 12/04/2023 14:04:14
hansard heading	Coronavirus: Vaccination
house id	2
identifier	HL6944
legislature	25277 pref label House of Lords
parliament number	58
question first answered	12/04/2023 13:33:00
question text	To ask His Majesty's Government what are their reasons for implementing restrictions on the spring 2023 COVID-19 booster programme; and what factors were considered in determining the eligibility criteria for the booster programme.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL6944
type	WrittenParliamentaryQuestion
uin	HL6944
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn

1604683

human indexable
published
registered interest
answer date	29/03/2023
date	15/03/2023
date tabled	15/03/2023
ddp created	15/03/2023 21:52:08
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	15/03/2023 21:56:29 11/04/2023 12:40:45
hansard heading	Coronavirus: Immunosuppression
house id	2
identifier	HL6530
legislature	25277 pref label House of Lords
parliament number	58
question first answered	11/04/2023 12:09:24
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 1 March (HL5824), which body will assume responsibility for ensuring that the immunocompromised will continue to be treated as a priority after the disbanding of the Antivirus and Therapeutics Taskforce, and its related programme and strategy boards.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL6530
type	WrittenParliamentaryQuestion
uin	HL6530
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn

1599737

human indexable
published
registered interest
answer date	13/03/2023
date	27/02/2023
date tabled	27/02/2023
ddp created	27/02/2023 23:06:28
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	27/02/2023 23:18:25 05/04/2023 15:19:14
hansard heading	Evusheld
house id	2
identifier	HL5936
legislature	25277 pref label House of Lords
parliament number	58
question first answered	05/04/2023 14:48:03
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 7 February (HL4942) which confirmed that the expert working group established specifically to review Evusheld pre-exposure prophylaxis only met twice, the last meeting being on 19 May 2022, why the parliamentary Written Answers provided from that date until 4 July 2022 refer to asking clinicians to advise on the most appropriate option; and what other advice was being received during this period.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL5936
type	WrittenParliamentaryQuestion
uin	HL5936
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn

1604682

human indexable
published
registered interest
answer date	29/03/2023
date	15/03/2023
date tabled	15/03/2023
ddp created	15/03/2023 21:52:07
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	15/03/2023 21:56:26 05/04/2023 15:20:18
hansard heading	Coronavirus: Medical Treatments
house id	2
identifier	HL6529
legislature	25277 pref label House of Lords
parliament number	58
question first answered	05/04/2023 14:49:00
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 7 March 2023 (HL5695), to which body the recommendations on the relevant cohorts for COVID-19 therapeutics are to be made, as discussed by the Chair of the Therapeutics Clinical Review Panel on 2 February; and whether the preparation of these recommendations included reviewing details within the report Qcovid 4 - Predicting risk of death or hospitalisation from COVID-19, published in August 2022.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL6529
type	WrittenParliamentaryQuestion
uin	HL6529
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn

1604709

human indexable
published
registered interest
answer date	29/03/2023
date	15/03/2023
date tabled	15/03/2023
ddp created	15/03/2023 21:56:04
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	15/03/2023 22:05:26 05/04/2023 15:20:19
hansard heading	Coronavirus: Immunosuppression
house id	2
identifier	HL6532
legislature	25277 pref label House of Lords
parliament number	58
question first answered	05/04/2023 14:48:38
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 14 March (HL5699), and as set out in the attachment to the Written Answer NICE nMABs appraisal committee paper, what assessment they have made of the finding that the prioritised list of people with conditions for which it may be clinically advantageous to receive neutralising monoclonal antibodies prophylaxis numbers 1.8 million.
session	2022/23
session number	3
tabling member printed	Lord Mendelsohn
title	House of Lords Tabled Parliamentary Question 2022/23 HL6532
type	WrittenParliamentaryQuestion
uin	HL6532
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4286 label Biography information for Lord Mendelsohn
publisher	25277 pref label House of Lords
tabling member	4286 label Biography information for Lord Mendelsohn